Pharma Focus Asia

Nona Biosciences and GeneQuantum Healthcare Forge Strategic Alliance to Enhance Early Discovery of Next-Generation Bioconjugates

Tuesday, November 14, 2023

Nona Biosciences, a global leader in technology innovation and antibody discovery and development solutions, has recently announced a strategic partnership with GeneQuantum Healthcare. The collaboration aims to advance the early discovery of next-generation bioconjugates, combining Nona Biosciences' Harbour Mice® platform and advanced technologies with GeneQuantum's exclusive iLDC (intelligent Ligase-dependent Conjugation) and iGDC (intelligent Glycotransferase-dependent conjugation) platforms.

The partnership will synergize the strengths of both companies to enhance technology platform capabilities, providing a comprehensive solution for global partners engaged in the early discovery of next-generation bioconjugates.

Nona Biosciences, expressed enthusiasm about the collaboration, stating, "Leveraging our cutting-edge antibody technologies and extensive experience in antibody research and development, Nona is committed to providing innovative, diverse, and customized solutions for preclinical drug development. We look forward to collaborating with GeneQuantum Healthcare to continuously enhance the capabilities of innovative bioconjugate drug research and development, empowering global partners to advance their ADC drug R&D initiatives."

GeneQuantum Healthcare's Founder and Chairman, Gang Qin, PhD, highlighted the significance of their core technologies, iLDC and iGDC platforms, in addressing challenges prevalent in the ADC field. He emphasized the technologies' ability to reduce production costs, improve drug quality, and enhance global accessibility to ADC drugs. Qin expressed honor in collaborating with Nona Biosciences, stating, "By leveraging GeneQuantum's conjugation technology and Nona's extensive drug development experience, we believe that this collaboration will substantially improve high-quality and high-throughput screening for the early discovery of ADC drugs."

 

Source: prnasia.com

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024